Clinical Trial Update: A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating romiplostim to prevent chemotherapy-induced low platelets in children and young adults with solid tumors; the study was terminated and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Tumor, Solid Tumor, Childhood | Phase 2 | Status: TERMINATED | Results posted: 2023-11-18